VYGR: Voyager Therapeutics Inc. Stocks News on March 31, 2025

Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025

VYGR

GlobeNewswire

9 hours ago

Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025

VYGR

Thomson Reuters StreetEvents

19 days ago

Q4 2024 Voyager Therapeutics Inc Earnings Call

VYGR

Zacks

20 days ago

Voyager Therapeutics (VYGR) Reports Q4 Loss, Misses Revenue Estimates

VYGR

Associated Press Finance

20 days ago

Voyager Therapeutics: Q4 Earnings Snapshot

Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

VYGR

GlobeNewswire

20 days ago

Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast

VYGR

GlobeNewswire

a month ago

Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast

New tau candidates, including an RNA therapy from Voyager, drive a multi-pronged Alzheimer’s approach

VYGR

Pharma Voice

a month ago

New tau candidates, including an RNA therapy from Voyager, drive a multi-pronged Alzheimer’s approach

VYGR

MT Newswires

a month ago

Voyager Therapeutics Reports Positive Trial Results From Alzheimer's Disease Treatment

Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer’s Disease

VYGR

GlobeNewswire

a month ago

Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer’s Disease

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences

VYGR

GlobeNewswire

a month ago

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences

VYGR

Insider Monkey

2 months ago

Voyager Therapeutics, Inc. (VYGR): A Cheap Biotech Stock to Invest In Now

VYGR

MT Newswires

2 months ago

Wedbush Adjusts Price Target on Voyager Therapeutics to $9 From $11, Maintains Outperform Rating

VYGR

MT Newswires

2 months ago

Voyager Therapeutics Shares Fall After Dropping Plan for VY9323 IND Filing in Mid-2025

Voyager Provides Update on SOD1 ALS Gene Therapy Program

VYGR

GlobeNewswire

2 months ago

Voyager Provides Update on SOD1 ALS Gene Therapy Program

Voyager to Present at Oppenheimer 25th Annual Healthcare Life Sciences Conference

VYGR

GlobeNewswire

2 months ago

Voyager to Present at Oppenheimer 25th Annual Healthcare Life Sciences Conference

VYGR

Zacks

2 months ago

What Makes Voyager Therapeutics (VYGR) a New Buy Stock

VYGR

MT Newswires

3 months ago

Cantor Fitzgerald Initiates Voyager Therapeutics at Overweight

VYGR

Insider Monkey

3 months ago

Voyager Therapeutics, Inc. (VYGR): Is This Gene Therapy Stock a Good Buy Right Now?

3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025

VYGR

Zacks

3 months ago

3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025

VYGR

Simply Wall St.

4 months ago

Institutional investors own a significant stake of 48% in Voyager Therapeutics, Inc. (NASDAQ:VYGR)

VYGR

Zacks

4 months ago

Wall Street Analysts See a 152.53% Upside in Voyager Therapeutics (VYGR): Can the Stock Really Move This High?

Wedbush upgrades Voyager to Outperform on pipeline progress

VYGR

TipRanks

4 months ago

Wedbush upgrades Voyager to Outperform on pipeline progress

VYGR

MT Newswires

4 months ago

Wedbush Upgrades Voyager Therapeutics to Outperform From Neutral, Raises Price Target to $11 From $7

VYGR

MT Newswires

4 months ago

Voyager Therapeutics Selects Development Candidate for Tau Silencing Program in Alzheimer's Disease

Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease

VYGR

GlobeNewswire

4 months ago

Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease

VYGR

Simply Wall St.

5 months ago

Declining Stock and Decent Financials: Is The Market Wrong About Voyager Therapeutics, Inc. (NASDAQ:VYGR)?

VYGR

Thomson Reuters StreetEvents

5 months ago

Q3 2024 Voyager Therapeutics Inc Earnings Call

VYGR

GuruFocus.com

5 months ago

Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...

VYGR

Zacks

5 months ago

Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates

VYGR

Associated Press Finance

5 months ago

Voyager Therapeutics: Q3 Earnings Snapshot

Voyager Reports Third Quarter 2024 Financial and Operating Results

VYGR

GlobeNewswire

5 months ago

Voyager Reports Third Quarter 2024 Financial and Operating Results

VYGR

GlobeNewswire

5 months ago

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences

Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast

VYGR

GlobeNewswire

5 months ago

Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast

Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

VYGR

Zacks

5 months ago

Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

VYGR

Zacks

5 months ago

Voyager Therapeutics (VYGR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

VYGR

MT Newswires

5 months ago

Leerink Partners Initiates Voyager Therapeutics at Outperform With $15 Price Target

VYGR

Simply Wall St.

6 months ago

Investing in Voyager Therapeutics (NASDAQ:VYGR) three years ago would have delivered you a 58% gain

Bicycle Therapeutics (BCYC) Soars 5.7%: Is Further Upside Left in the Stock?

VYGR

Zacks

6 months ago

Bicycle Therapeutics (BCYC) Soars 5.7%: Is Further Upside Left in the Stock?

VYGR

Zacks

6 months ago

Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength?

VYGR

MT Newswires

6 months ago

Voyager Therapeutics Says Third Gene Therapy Development Candidate Selected Under Neurocrine Collaboration

Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected

VYGR

GlobeNewswire

6 months ago

Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected

VYGR

Zacks

7 months ago

Novartis to License VYGR's Capsid for Gene Therapy in Neurology

VYGR

MT Newswires

7 months ago

Voyager Therapeutics Gets Capsid License for Gene Therapy Program From Novartis

Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14

VYGR

GlobeNewswire

7 months ago

Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VYGR

GlobeNewswire

7 months ago

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VYGR

GlobeNewswire

7 months ago

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences

VYGR

Simply Wall St.

8 months ago

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase

VYGR

GlobeNewswire

8 months ago

Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase

VYGR

Zacks

8 months ago

Voyager Therapeutics (VYGR) Reports Q2 Loss, Tops Revenue Estimates

VYGR

Associated Press Finance

8 months ago

Voyager Therapeutics: Q2 Earnings Snapshot

Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results

VYGR

GlobeNewswire

8 months ago

Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results

Voyager Therapeutics Announces Second Quarter 2024 Conference Call and Webcast

VYGR

GlobeNewswire

8 months ago

Voyager Therapeutics Announces Second Quarter 2024 Conference Call and Webcast

VYGR

GlobeNewswire

8 months ago

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VYGR

GlobeNewswire

9 months ago

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VYGR

Simply Wall St.

9 months ago

Voyager Therapeutics, Inc. (NASDAQ:VYGR) is definitely on the radar of institutional investors who own 49% of the company

Voyager Therapeutics to Present at Multiple Virtual Investor Conferences

VYGR

GlobeNewswire

10 months ago

Voyager Therapeutics to Present at Multiple Virtual Investor Conferences

VYGR

MT Newswires

10 months ago

Voyager Therapeutics Names Nathan Jorgensen as Finance Chief

Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer

VYGR

GlobeNewswire

10 months ago

Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

VYGR

GOBankingRates

10 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

VYGR

AFP

10 months ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

VYGR

AFP

10 months ago

Italy beat Bosnia in final Euros warm-up

Trump loyalists proud to support 'felon' at Las Vegas rally

VYGR

AFP

10 months ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

VYGR

Business Insider

10 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

VYGR

Insider Monkey

10 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

VYGR

Reuters

10 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

VYGR

Insider Monkey

10 months ago

Best Date Night Fragrance in 2024

Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease

VYGR

GlobeNewswire

10 months ago

Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease

VYGR

Thomson Reuters StreetEvents

a year ago

Q1 2024 Voyager Therapeutics Inc Earnings Call

VYGR

MT Newswires

a year ago

Wedbush Adjusts Voyager Therapeutics' PT to $8 From $10, Keeps Neutral Rating

VYGR

GuruFocus.com

a year ago

Voyager Therapeutics Inc (VYGR) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

VYGR

Zacks

a year ago

Voyager Therapeutics (VYGR) Reports Q1 Loss, Tops Revenue Estimates

VYGR

Associated Press Finance

a year ago

Voyager Therapeutics: Q1 Earnings Snapshot

Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results

VYGR

GlobeNewswire

a year ago

Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results

Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting

VYGR

GlobeNewswire

a year ago

Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting

VYGR

Simply Wall St.

a year ago

Voyager Therapeutics' (NASDAQ:VYGR) three-year earnings growth trails the splendid shareholder returns

Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast

VYGR

GlobeNewswire

a year ago

Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast

Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates

VYGR

Zacks

a year ago

Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates

Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates

VYGR

Zacks

a year ago

Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates

Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting

VYGR

GlobeNewswire

a year ago

Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting

Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment

VYGR

GlobeNewswire

a year ago

Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment

VYGR

Simply Wall St.

a year ago

Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Buy Voyager Stock, Analyst Says. The Little Biotech Could Have Big Breakthroughs.

VYGR

Barrons.com

a year ago

Buy Voyager Stock, Analyst Says. The Little Biotech Could Have Big Breakthroughs.

VYGR

GlobeNewswire

a year ago

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer

VYGR

GlobeNewswire

a year ago

Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer

12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds

VYGR

Insider Monkey

a year ago

12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds

VYGR

Simply Wall St.

a year ago

Analysts Just Made A Major Revision To Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Revenue Forecasts

VYGR

Thomson Reuters StreetEvents

a year ago

Q4 2023 Voyager Therapeutics Inc Earnings Call

VYGR

Insider Monkey

a year ago

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q4 2023 Earnings Call Transcript

VYGR

GuruFocus.com

a year ago

Voyager Therapeutics Inc (VYGR) Announces Strong Year-End Financials with Significant Cash Position

VYGR

Associated Press Finance

a year ago

Voyager Therapeutics: Q4 Earnings Snapshot

Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

VYGR

GlobeNewswire

a year ago

Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment

VYGR

GlobeNewswire

a year ago

Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment

Novavax (NVAX) Surges 8.4%: Is This an Indication of Further Gains?

VYGR

Zacks

a year ago

Novavax (NVAX) Surges 8.4%: Is This an Indication of Further Gains?

Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast

VYGR

GlobeNewswire

a year ago

Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast

Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer’s Disease and Advances Program into Late Research

VYGR

GlobeNewswire

a year ago

Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer’s Disease and Advances Program into Late Research

Voyager Therapeutics to Present at the Oppenheimer Annual Life Sciences Conference

VYGR

GlobeNewswire

a year ago

Voyager Therapeutics to Present at the Oppenheimer Annual Life Sciences Conference

Dave Ramsey: 10 Genius Things To Do With Your Money

VYGR

GOBankingRates

a year ago

Dave Ramsey: 10 Genius Things To Do With Your Money

CoStar Group to Report Financial Results for Fourth Quarter and Full Year 2023 on February 20, 2024

VYGR

Business Wire

a year ago

CoStar Group to Report Financial Results for Fourth Quarter and Full Year 2023 on February 20, 2024

Kearny Financial Corp. Revises Second Quarter Fiscal 2024 Results

VYGR

GlobeNewswire

a year ago

Kearny Financial Corp. Revises Second Quarter Fiscal 2024 Results

Amazon's abandoned acquisition leaves iRobot in Carlyle debt straightjacket

VYGR

Reuters

a year ago

Latest Voyager Therapeutics Inc. (VYGR) News on March 31, 2025

Share on Social Networks: